Michael Laffan is Professor of Haemostasis and Thrombosis in the department of haematology.He trained in medicine at the University of Oxford and trained in haematology at the Hammersmith and Royal Free hospitals. His principal research interests are the structure function relationship of von Willebrand factor, in particular the role of glycosylation, and the mechanisms and regulation of thrombin generation. He is director of the Hammersmith Hospital Haemophilia centre and is responsible for postgraduate education in haematology.
et al., 2023, Multiple myeloma and its treatment contribute to increased platelet reactivity., Platelets, Vol:34
et al., 2023, Thrombosis, major bleeding, and survival in COVID-19 supported by VV- ECMO in the first vs second wave- multicentre observational study in the UK, Journal of Thrombosis and Haemostasis, Vol:21, ISSN:1538-7836, Pages:2735-2746
et al., 2023, The effects of pathogenic variants for inherited hemostasis disorders in 140,214 UK Biobank participants., Blood
et al., 2023, Safety and Efficacy of Therapeutic Anticoagulation with Subcutaneous Unfractionated Heparin in Patients with Renal Failure, Seminars in Thrombosis and Hemostasis, ISSN:0094-6176
et al., 2023, Impact of thromboprophylaxis on hospital acquired thrombosis following discharge in patients admitted with COVID-19: multicentre observational study in the UK, British Journal of Haematology, Vol:202, ISSN:0007-1048, Pages:485-497